Skip to content

Clinical study on Xu's thirteen ghost points for the treatment of liver depression and fire type insomnia with anxiety state

Clinical study on Xu's thirteen ghost points for the treatment of liver depression and fire type insomnia with anxiety state

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080176
Enrollment
Unknown
Registered
2024-01-22
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

treatment group:Acupuncture points: Renzhong, Shenting, Fengfu, Chengjian, Cheqiqi, Shaoshang, Daling, Maijie, Yanglingquan, Yinbai, Xingmai, according to the order of acupuncture
comparison group:Acupuncture points: Baihui, Shenmen, Sanyinjiao, Zhaohai, Shenwei, Anmian, Shishencong, Fengchi, Xingma, Manxi,according to the order of acupuncture

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for insomnia in Western medicine; (2) Meet the diagnostic criteria of Chinese medicine for insomnia and liver depression and fire syndrome; (3) Age between 18-65 years old, male and female gender are not required; (4) The patient's score of 7 = PSQI score = 16; (5) The patient's 14 points = HAMA score = 29 points; (6) No participation in clinical trials in the previous month; (7) Those who have clear consciousness, can actively cooperate in filling out the questionnaires and scales, and actively cooperate in the treatment process; (8) Voluntary participation and signing of informed consent;

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria for insomnia; (2) Those with systemic diseases such as pain, fever, cough, surgery, etc., as well as those caused by external environmental disturbances; (3) Combined with serious primary diseases of heart, lung and other systems; (4) Those with combined organic mental disorders or drug-induced insomnia; (5) Patients with combined depression; (6) Those who do not accept or cooperate with the survey.

Design outcomes

Primary

MeasureTime frame
Symptoms and signs score;Pittsburgh Sleep Quality Index Scale;Hamilton Anxiety Inventory;Insomnia Severity Index;Sleep Diary;

Secondary

MeasureTime frame
serum cortisol;5-HT;Sleep ACT test;

Countries

CHINA

Contacts

Public Contactchenyidan

Zhejiang Hospital

chenyidan0908@vip.126.com+86 132 2106 7998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026